| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| FOR |
| JANUS MEDICAL REPORTING LIMITED |
| REGISTERED NUMBER: |
| UNAUDITED FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| FOR |
| JANUS MEDICAL REPORTING LIMITED |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| CONTENTS OF THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| Page |
| Company information | 1 |
| Balance sheet | 2 |
| Notes to the financial statements | 4 |
| JANUS MEDICAL REPORTING LIMITED |
| COMPANY INFORMATION |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| DIRECTOR: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Elfed House |
| Oak Tree Court |
| Cardiff Gate Business Park |
| Cardiff |
| CF23 8RS |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| BALANCE SHEET |
| 31 MARCH 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| FIXED ASSETS |
| Tangible assets | 4 |
| Investments | 5 |
| CURRENT ASSETS |
| Debtors | 6 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 7 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| Revaluation reserve |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| BALANCE SHEET - continued |
| 31 MARCH 2025 |
| The financial statements were approved and authorised for issue by the director and authorised for issue on |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| NOTES TO THE FINANCIAL STATEMENTS |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 1. | STATUTORY INFORMATION |
| Janus Medical Reporting Limited is a |
| The company's functional and presentational currency in the financial statements is Sterling (£), rounded to the nearest pound. |
| The significant accounting policies applied in the presentation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated. |
| 2. | ACCOUNTING POLICIES |
| BASIS OF PREPARING THE FINANCIAL STATEMENTS |
| There have been no departures from Financial Reporting Standard 102. |
| PREPARATION OF CONSOLIDATED FINANCIAL STATEMENTS |
| The financial statements contain information about Janus Medical Reporting Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements. |
| RELATED PARTY EXEMPTION |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions within the group. |
| TURNOVER |
| Turnover is recognised at the date of provision of medical and other services or the date of issue of the medical report and is represented by fees receivable excluding value added tax. |
| TANGIBLE FIXED ASSETS |
| Plant and machinery | - |
| Motor vehicles | - |
| Tangible fixed assets are initially measured at cost. After initial recognition, tangible fixed assets are measured at cost less any accumulated depreciation and any accumulated impairment losses. |
| FINANCIAL INSTRUMENTS |
| Basic financial instruments are recognised at amortised cost |
| TAXATION |
| Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantively enacted at the balance sheet date. |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 2. | ACCOUNTING POLICIES - continued |
| DEFERRED TAX |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| FIXED ASSET INVESTMENTS |
| Investments in subsidiary companies are stated at cost of acquisition subject to any impairment assessed at the period end. |
| Other fixed asset investments are included at fair value, considered on an annual basis. Revaluation gains are recongised in income and accumulated equity and are recognised in profit and loss to the extent that they reverse a revaluation decrease of the same asset previously recognised in the profit and loss. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | TANGIBLE FIXED ASSETS |
| Plant and | Motor |
| machinery | vehicles | Totals |
| £ | £ | £ |
| COST |
| At 1 April 2024 |
| Additions |
| At 31 March 2025 |
| DEPRECIATION |
| At 1 April 2024 |
| Charge for year |
| At 31 March 2025 |
| NET BOOK VALUE |
| At 31 March 2025 |
| At 31 March 2024 |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 5. | FIXED ASSET INVESTMENTS |
| Shares in |
| group | Other |
| undertakings | investments | Totals |
| £ | £ | £ |
| COST OR VALUATION |
| At 1 April 2024 | 8,747 |
| Revaluations | 1,215 |
| At 31 March 2025 | 9,962 |
| NET BOOK VALUE |
| At 31 March 2025 | 9,962 |
| At 31 March 2024 | 8,747 |
| Cost or valuation at 31 March 2025 is represented by: |
| Shares in |
| group | Other |
| undertakings | investments | Totals |
| £ | £ | £ |
| Valuation in 2025 | - | 9,761 | 9,761 |
| Cost | 201 | - | 201 |
| 201 | 9,761 | 9,962 |
| If other fixed asset investments had not been revalued they would have been included at the following historical cost: |
| 2025 | 2024 |
| £ | £ |
| Cost | 7,226 | 7,226 |
| Other fixed asset investments were valued on an open market value basis on 31 March 2025 by the director . |
| 6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Debtors |
| Amounts owed by group undertakings |
| VAT |
| JANUS MEDICAL REPORTING LIMITED (REGISTERED NUMBER: 05098388) |
| NOTES TO THE FINANCIAL STATEMENTS - continued |
| FOR THE YEAR ENDED 31 MARCH 2025 |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Trade creditors |
| Accruals |
| Social security and other taxes |
| Other creditors |
| Directors' current accounts |
| 8. | OTHER FINANCIAL COMMITMENTS |
| The company has guaranteed support for its subsidiary companies and as at 31 March 2025 the amounts owed by the subsidiary companies amounted to £1,229,132 (2024: £1,235,857, with the following amounts owed by the individual companies: |
| 31.3.25 | 31.3.24 |
| £ | £ |
| First Air Limited | 10,362 | 3,344 |
| Llanedi Green Limited | 24,834 | 24,834 |
| Safe Roost Limited | 859,216 | 873,460 |
| Nead Sabhailte Limited | 334,719 | 334,219 |